Start with the care that fits your sore joint

Easy movement and simple support often help first

Shorter walks, lighter lifting, or a day between hard chores may calm the ache. Don't add more work unless the next morning feels no worse.

A cane, brace, or better shoes may take strain off the joint. These aids won't suit everyone, so ask your doctor or physical therapist how to use them.

Creams or pills may help, but medicines aren't harmless. Your heart, kidneys, stomach, bleeding risk, and other pills all matter before you choose one.

QC Kinetix offers non-surgical choices

QC Kinetix calls its blood-based choices regenerative treatments. The medical providers who examine you are licensed clinicians.

For platelet-rich plasma, staff take some blood from your arm and spin it. The part holding more platelets is placed into the sore joint.

This care is offered to ease soreness and improve movement, though it doesn't help everyone. Ask about the number of appointments and the full price for them.

Ask how the clinic will measure any change. You'll also need to know what help is offered if relief is limited.

Surgery makes sense only for the right joint

Some worn or badly damaged joints do need surgery, and waiting forever isn't wise. That choice depends on the exam, your health, daily limits, and earlier care.

Knee or hip surgery alternatives can be discussed at QC Kinetix after the soreness is examined. These choices can't replace urgent care or medicine when the body's defenses are attacking several joints.

Compare the time, cost, risks, and likely help from each choice. Then you'll be able to decide without being hurried.

Sources

1. A Cochrane overview of 21 systematic reviews (381 studies, 37,143 participants) covering rheumatoid arthritis, osteoarthritis, fibromyalgia, low back pain, neck disorder and other chronic pain conditions concluded that physical activity and exercise are interventions with few adverse events that may improve pain severity and physical function - but that the quality of the evidence is low, effects on pain were inconsistent across reviews, and physical function improved significantly in 14 reviews with only small-to-moderate effect sizes. The commonest reported adverse event was increased muscle soreness that settled within weeks.

   Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH — Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.. Cochrane Database of Systematic Reviews, 2017. DOI: 10.1002/14651858.CD011279.pub3.

2. OARSI's 2019 guideline is the only major osteoarthritis guideline that grades treatments separately for people with disease in MULTIPLE joints. Its Core Treatments for polyarticular OA are arthritis education and structured land-based exercise. Critically, intra-articular corticosteroid and intra-articular hyaluronic acid were Level 1B/2 options for knee OA only and were NOT recommended for hip or polyarticular OA; oral NSAIDs were not recommended at all for people with cardiovascular comorbidity or frailty; and paracetamol/acetaminophen was conditionally not recommended.

   Bannuru RR, Osani MC, Vaysbrot EE, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.. Osteoarthritis and Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

3. FDA states verbatim that of the products marketed as regenerative medicine - stem cell products, stromal vascular fraction from adipose tissue, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products - 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently no FDA-approved exosome products.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA (Center for Biologics Evaluation and Research), 2024.

4. In a longitudinal general-population cohort of 1,753 young adults followed across two waves three years apart, sleep problems were associated cross-sectionally with chronic pain and with musculoskeletal, headache and abdominal pain severity, and prospectively PREDICTED chronic pain and an increase in musculoskeletal pain severity three years later. The prospective effect was stronger in women.

   Bonvanie IJ, Oldehinkel AJ, Rosmalen JGM, Janssens KAM — Sleep problems and pain: a longitudinal cohort study in emerging adults.. Pain, 2016. DOI: 10.1097/j.pain.0000000000000466.